Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Harvard Business School
Dow
Medtronic
McKinsey

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 7,635,695

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 7,635,695
Title:Antiinflammation agents
Abstract: Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic, infectious and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism, infection and cell proliferation. The subject compounds contain a fused heterobicyclic ring.
Inventor(s): Burkitt; Simon A. (Kirkby-in-Ashfield, GB), Cardozo; Mario G. (San Francisco, CA), Cushing; Timothy D. (Pacifica, CA), DeGraffenreid; Michael R. (San Francisco, CA), Farthing; Christopher N. (Macclesfield, GB), Hao; Xiaolin (Foster City, CA), Jaen; Juan C. (Burlingame, CA), Jiao; Xian Yun (San Mateo, CA), Kopecky; David J. (San Francisco, CA), Labelle; Marc (Burlingame, CA), Lively; Sarah E. (Congleton, GB), McMinn; Dustin L. (Pacifica, CA), Rasmussen; Sven P. (Congleton, GB), Shin; Youngsook (San Mateo, CA), Smith; Marie-Louise (Half Moon Bay, CA), Smith; Andrew (Macclesfield, GB)
Assignee: Amgen Inc. (South San Francisco, CA)
Application Number:11/709,895
Patent Claims:see list of patent claims

Details for Patent 7,635,695

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 1998-08-24 ⤷  Try it Free 2022-10-31
Immunex Corporation ENBREL etanercept For Injection 103795 1998-11-02 ⤷  Try it Free 2022-10-31
Immunex Corporation ENBREL etanercept For Injection 103795 1999-05-27 ⤷  Try it Free 2022-10-31
Immunex Corporation ENBREL etanercept Injection 103795 2004-09-27 ⤷  Try it Free 2022-10-31
Immunex Corporation ENBREL etanercept Injection 103795 2007-02-01 ⤷  Try it Free 2022-10-31
Immunex Corporation ENBREL MINI etanercept Injection 103795 2017-09-14 ⤷  Try it Free 2022-10-31
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
McKesson
Merck
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.